Antiviral-antibody combination improves influenza outcomes in mice
Researchers at McMaster University found in a mouse study that combining a class of well-known antiviral drugs and neutralizing antibodies was more effective than either approach alone, which they contend could be used to treat seasonal influenza and help prevent the next flu pandemic. Read More
New antibody neutralizes all known SARS-CoV-2 variants: study
An antibody developed at Boston Children’s Hospital neutralizes all known SARS-CoV-2 variants, including omicron subvariants, which may inform the design of future COVID-19 vaccines. Read More
Timothy Hunt to take helm of ARM as new CEO
The Alliance for Regenerative Medicine (ARM) has announced that Timothy Hunt will succeed Janet Lambert as chief executive officer (CEO) of the Washington, DC-based advocacy organization, which represents the cell and gene therapy industry. Read More
‘Jumping gene’ affects immune system response, helps mice survive virus infections
Australian researchers have learned a particular transposable element, a “jumping gene,” has a profound effect on the immune response to virus infection, at least in mice. Read More
Antibodies create broad SARS immune response: study
Scientists from Scripps Research have discovered certain antibodies are capable of immunity against many different SARS-CoV-2 variants, as well as other SARS viruses like SARS-CoV-1. Read More
Video from AACC: First impressions, Day 1
Reflecting on highlights from the LabPulse.com and ScienceBoard.net team for Day 1, Kalorama Information's Bruce Carlson compares AACC 2022 with previous meetings. Read More
Video from AACC: Enzo BioChem CEO on COVID-19 test landscape
Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves. Read More
Seegene outlines expansion strategies at AACC 2022
Seegene provided a glimpse of its global expansion initiatives at the 2022 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Chicago, held July 26-28. Read More
Intranasal COVID-19 vaccine tops vaccine injection
Ohio researchers have discovered a new way of delivering the COVID-19 vaccine: up the nose. It could one day be incorporated into the existing measles-mumps-rubella vaccine as a way to produce COVID-19 immunity in kids. Read More
CRISPR-based study identifies lung proteins that promote, protect against SARS-CoV-2 infections
A study led by University of California, Berkeley researchers has identified specific proteins within the human body that can either promote SARS-CoV-2 infections or protect against them, a discovery they contend could lead to new antiviral therapies. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
